Filing Details
- Accession Number:
- 0001209191-17-058227
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-27 19:40:26
- Reporting Period:
- 2017-10-27
- Accepted Time:
- 2017-10-27 19:40:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1437786 | Immune Design Corp. | IMDZ | Pharmaceutical Preparations (2834) | 262007174 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1606074 | Peter Svennilson | C/O Immune Design Corp. 1616 Eastlake Avenue. E., Suite 310 Seattle WA 98102 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-10-27 | 2,681,000 | $4.10 | 2,681,000 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 800,000 | Indirect | See Footnote |
Common Stock | 3,161,942 | Indirect | See Footnote |
Footnotes
- The securities are directly held by Ponoi Capital, LP ("Ponoi Capital") and indirectly held by Ponoi Management, LLC ("Ponoi Management"), the general partner of Ponoi Capital. Ponoi Management has voting and dispositive power with respect to the shares owned by Ponoi Capital. Mr. Svennilson is a managing partner of Ponoi Management and may be deemed to have shared voting and dispositive power over the shares owned by Ponoi Capital. Mr. Svennilson disclaims beneficial ownership of all shares held by Ponoi Capital, except to the extent of his actual pecuniary interest therein.
- The securities are directly held by The Column Group II, LP ("The Column Group II") and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of The Column Group II. TCG II GP has voting and dispositive power with respect to the shares owned by The Column Group II. Mr. Svennilson is a managing partner of TCG II GP and may be deemed to have shared voting and dispositive power over the shares owned by The Column Group II. Mr. Svennilson disclaims beneficial ownership of all shares held by The Column Group II, except to the extent of his actual pecuniary interest therein.
- The securities are directly held by The Column Group, LP ("The Column Group") and indirectly held by The Column Group GP, LP ("TCG GP"), the general partner of The Column Group. TCG GP has voting and dispositive power with respect to the shares owned by The Column Group. Mr. Svennilson is a managing partner of TCG GP and may be deemed to have shared voting and dispositive power over the shares owned by The Column Group. Mr. Svennilson disclaims beneficial ownership of all shares held by The Column Group, except to the extent of his actual pecuniary interest therein.